Share on StockTwits

Idera Pharmaceuticals (NASDAQ:IDRA) is set to issue its Q214 quarterly earnings data on Tuesday, August 12th. Analysts expect Idera Pharmaceuticals to post earnings of ($0.09) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Idera Pharmaceuticals (NASDAQ:IDRA) last released its earnings data on Tuesday, May 13th. The company reported ($0.12) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.08) by $0.04. During the same quarter in the prior year, the company posted ($0.15) earnings per share. On average, analysts expect Idera Pharmaceuticals to post $-0.40 EPS for the current fiscal year and $-0.44 EPS for the next fiscal year.

Idera Pharmaceuticals (NASDAQ:IDRA) opened at 2.75 on Monday. Idera Pharmaceuticals has a 1-year low of $1.45 and a 1-year high of $6.87. The stock’s 50-day moving average is $2.76 and its 200-day moving average is $3.68. The company’s market cap is $226.7 million.

Idera Pharmaceuticals, Inc is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (NASDAQ:IDRA) – and ribonucleic acid (RNA) – based drug candidates.

Receive News & Ratings for Idera Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idera Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.